Chinese herbal medicine Dengzhan Xixin injection for acute ischemic stroke: A systematic review and meta-analysis of randomised controlled trials
•The effectiveness and safety of DZXX injection for AIS was analysed.•It appears that DZXX can additionally improve neurological function for AIS patients.•The addition of DZXX injection to CT appears to be safe for patients with AIS.•More large, rigorous and adequately reported trials are needed to...
Saved in:
Published in | Complementary therapies in medicine Vol. 34; pp. 74 - 85 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Scotland
Elsevier Ltd
01.10.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •The effectiveness and safety of DZXX injection for AIS was analysed.•It appears that DZXX can additionally improve neurological function for AIS patients.•The addition of DZXX injection to CT appears to be safe for patients with AIS.•More large, rigorous and adequately reported trials are needed to confirm our findings.
To evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic stroke.
Systematic review and meta-analysis (CRD42016038413, http://www.crd.york.ac.uk/PROSPERO).
Six electronic databases were searched from inception to March 2016 for randomised controlled trials (RCTs) of Dengzhan Xixin (DZXX) injection for acute ischemic stroke. The methodological quality of RCTs was assessed by the Cochrane risk of bias tool.
was performed using RevMan 5.3 and was presented with mean difference (MD) or relative risk (RR) and their 95% confidence interval (CI). A summary of finding table was generated by GRADEpro (version 3.6).
Twenty-five RCTs with 2498 participants were included and all trials adopted conventional therapy (CT) in both arms. Most of the studies had high risk of bias. The addition of DZXX to CT showed no significant benefit on death (RR 0.27, 95% CI 0.05–1.63) within the treatment period (14–35 d), but showed higher Barthel index score (MD 10.20, 95% CI 8.16–12.25), lower neurological function deficit score (MD −3.99, 95% CI −5.68 to −2.30, by NFDS; MD −1.67, 95% CI −2.59 to −0.76, by NIHSS), and lower treatment failure (RR 0.40, 95% CI 0.31–0.52). Thirteen trials (52%) reported the outcome of adverse events, but no serious adverse events were reported.
Low quality evidence implied that DZXX injection appeared to improve neurological function in patients with acute ischemic stroke. However, this potential benefit should be further studied in large, rigorous trials. |
---|---|
AbstractList | OBJECTIVETo evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic stroke.DESIGNSystematic review and meta-analysis (CRD42016038413, http://www.crd.york.ac.uk/PROSPERO).METHODSSix electronic databases were searched from inception to March 2016 for randomised controlled trials (RCTs) of Dengzhan Xixin (DZXX) injection for acute ischemic stroke. The methodological quality of RCTs was assessed by the Cochrane risk of bias tool.DATA SYNTHESISwas performed using RevMan 5.3 and was presented with mean difference (MD) or relative risk (RR) and their 95% confidence interval (CI). A summary of finding table was generated by GRADEpro (version 3.6).RESULTSTwenty-five RCTs with 2498 participants were included and all trials adopted conventional therapy (CT) in both arms. Most of the studies had high risk of bias. The addition of DZXX to CT showed no significant benefit on death (RR 0.27, 95% CI 0.05-1.63) within the treatment period (14-35 d), but showed higher Barthel index score (MD 10.20, 95% CI 8.16-12.25), lower neurological function deficit score (MD -3.99, 95% CI -5.68 to -2.30, by NFDS; MD -1.67, 95% CI -2.59 to -0.76, by NIHSS), and lower treatment failure (RR 0.40, 95% CI 0.31-0.52). Thirteen trials (52%) reported the outcome of adverse events, but no serious adverse events were reported.CONCLUSIONLow quality evidence implied that DZXX injection appeared to improve neurological function in patients with acute ischemic stroke. However, this potential benefit should be further studied in large, rigorous trials. •The effectiveness and safety of DZXX injection for AIS was analysed.•It appears that DZXX can additionally improve neurological function for AIS patients.•The addition of DZXX injection to CT appears to be safe for patients with AIS.•More large, rigorous and adequately reported trials are needed to confirm our findings. To evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic stroke. Systematic review and meta-analysis (CRD42016038413, http://www.crd.york.ac.uk/PROSPERO). Six electronic databases were searched from inception to March 2016 for randomised controlled trials (RCTs) of Dengzhan Xixin (DZXX) injection for acute ischemic stroke. The methodological quality of RCTs was assessed by the Cochrane risk of bias tool. was performed using RevMan 5.3 and was presented with mean difference (MD) or relative risk (RR) and their 95% confidence interval (CI). A summary of finding table was generated by GRADEpro (version 3.6). Twenty-five RCTs with 2498 participants were included and all trials adopted conventional therapy (CT) in both arms. Most of the studies had high risk of bias. The addition of DZXX to CT showed no significant benefit on death (RR 0.27, 95% CI 0.05–1.63) within the treatment period (14–35 d), but showed higher Barthel index score (MD 10.20, 95% CI 8.16–12.25), lower neurological function deficit score (MD −3.99, 95% CI −5.68 to −2.30, by NFDS; MD −1.67, 95% CI −2.59 to −0.76, by NIHSS), and lower treatment failure (RR 0.40, 95% CI 0.31–0.52). Thirteen trials (52%) reported the outcome of adverse events, but no serious adverse events were reported. Low quality evidence implied that DZXX injection appeared to improve neurological function in patients with acute ischemic stroke. However, this potential benefit should be further studied in large, rigorous trials. ObjectiveTo evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic stroke.DesignSystematic review and meta-analysis (CRD42016038413, http://www.crd.york.ac.uk/PROSPERO).MethodsSix electronic databases were searched from inception to March 2016 for randomised controlled trials (RCTs) of Dengzhan Xixin (DZXX) injection for acute ischemic stroke. The methodological quality of RCTs was assessed by the Cochrane risk of bias tool.Data synthesiswas performed using RevMan 5.3 and was presented with mean difference (MD) or relative risk (RR) and their 95% confidence interval (CI). A summary of finding table was generated by GRADEpro (version 3.6).ResultsTwenty-five RCTs with 2498 participants were included and all trials adopted conventional therapy (CT) in both arms. Most of the studies had high risk of bias. The addition of DZXX to CT showed no significant benefit on death (RR 0.27, 95% CI 0.05–1.63) within the treatment period (14–35 d), but showed higher Barthel index score (MD 10.20, 95% CI 8.16–12.25), lower neurological function deficit score (MD −3.99, 95% CI −5.68 to −2.30, by NFDS; MD −1.67, 95% CI −2.59 to −0.76, by NIHSS), and lower treatment failure (RR 0.40, 95% CI 0.31–0.52). Thirteen trials (52%) reported the outcome of adverse events, but no serious adverse events were reported.ConclusionLow quality evidence implied that DZXX injection appeared to improve neurological function in patients with acute ischemic stroke. However, this potential benefit should be further studied in large, rigorous trials. To evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic stroke. Systematic review and meta-analysis (CRD42016038413, http://www.crd.york.ac.uk/PROSPERO). Six electronic databases were searched from inception to March 2016 for randomised controlled trials (RCTs) of Dengzhan Xixin (DZXX) injection for acute ischemic stroke. The methodological quality of RCTs was assessed by the Cochrane risk of bias tool. was performed using RevMan 5.3 and was presented with mean difference (MD) or relative risk (RR) and their 95% confidence interval (CI). A summary of finding table was generated by GRADEpro (version 3.6). Twenty-five RCTs with 2498 participants were included and all trials adopted conventional therapy (CT) in both arms. Most of the studies had high risk of bias. The addition of DZXX to CT showed no significant benefit on death (RR 0.27, 95% CI 0.05-1.63) within the treatment period (14-35 d), but showed higher Barthel index score (MD 10.20, 95% CI 8.16-12.25), lower neurological function deficit score (MD -3.99, 95% CI -5.68 to -2.30, by NFDS; MD -1.67, 95% CI -2.59 to -0.76, by NIHSS), and lower treatment failure (RR 0.40, 95% CI 0.31-0.52). Thirteen trials (52%) reported the outcome of adverse events, but no serious adverse events were reported. Low quality evidence implied that DZXX injection appeared to improve neurological function in patients with acute ischemic stroke. However, this potential benefit should be further studied in large, rigorous trials. |
Author | Lai, Lily Y.W. Wang, Li-qiong Liu, Jian-ping Xu, Hao Chen, Zhuo Li, Jin-gen Yang, Xiao-ying |
Author_xml | – sequence: 1 givenname: Jin-gen surname: Li fullname: Li, Jin-gen organization: Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China – sequence: 2 givenname: Li-qiong surname: Wang fullname: Wang, Li-qiong organization: Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China – sequence: 3 givenname: Xiao-ying surname: Yang fullname: Yang, Xiao-ying organization: Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China – sequence: 4 givenname: Zhuo surname: Chen fullname: Chen, Zhuo organization: Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 10091, China – sequence: 5 givenname: Lily Y.W. surname: Lai fullname: Lai, Lily Y.W. organization: Complementary and Integrated Medicine Research Unit, Primary Care and Population Sciences, University of Southampton, Southampton, UK – sequence: 6 givenname: Hao surname: Xu fullname: Xu, Hao email: xuhaotcm@hotmail.com organization: Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 10091, China – sequence: 7 givenname: Jian-ping surname: Liu fullname: Liu, Jian-ping email: jianping_l@hotmail.com, Liujp@bucm.edu.cn organization: Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28917378$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UcuO1DAQtNAidnbgBzggS1y4JPiRlxGX1cAuSCtxAYmb5TgdxiGxF9tZGP6CP6ZHs3DgwKmtVlW5q-qCnPnggZCnnJWc8eblVNrsllIw3pasKxmrHpAN71pZNKqRZ2TDVFMXQih1Ti5SmhhjSrbyETkXneKtbLsN-bXbOw8J6B5ib2a6wOAsbugb8F9-7o2nn90P56nzE-BvwdMxRGrsmoG6ZPewOEtTjuErvKKXNB1ShsVkXEa4c_CdGj-gaDaF8WY-JJdoGGnEbVhcgoHa4JE9z_jM0Zk5PSYPRxzw5H5uyaertx9374qbD9fvd5c3hZVdlQu01puhrwcxStOLXqhRWtsIO6pecluPfSsrYaztQMiKtbWFoek51EqKpmkHuSUvTrq3MXxbIWWNB1mYZ-MhrElzVTHBmMDEtuT5P9AprBH9JC0wRsnaphKIEieUjSGlCKO-jW4x8aA508fC9KSPheljYZp1GgtD0rN76bXH7P9S_jSEgNcnAGAWmGjUyTrw6MZFbEQPwf1P_zelcKuy |
CitedBy_id | crossref_primary_10_3389_fphar_2022_957483 crossref_primary_10_1111_jebm_12386 crossref_primary_10_1002_jssc_201800470 crossref_primary_10_1016_j_aimed_2018_11_002 crossref_primary_10_3389_fphar_2024_1395167 crossref_primary_10_3389_fphar_2021_712436 crossref_primary_10_1080_23802359_2019_1605854 crossref_primary_10_3389_fphar_2023_1091879 crossref_primary_10_1016_j_phrs_2019_104365 crossref_primary_10_3389_fphar_2022_877872 crossref_primary_10_22246_jikm_2019_40_6_1081 crossref_primary_10_12998_wjcc_v11_i2_464 crossref_primary_10_1155_2020_2649843 crossref_primary_10_1016_j_jep_2024_118372 crossref_primary_10_1039_C9RA03917A crossref_primary_10_1002_ptr_8033 crossref_primary_10_1007_s11655_020_3094_7 crossref_primary_10_1002_jssc_202000661 crossref_primary_10_1155_2022_9803552 crossref_primary_10_4103_1673_5374_228711 crossref_primary_10_1002_ddr_21661 crossref_primary_10_1155_2021_6138854 crossref_primary_10_3233_JAD_210652 crossref_primary_10_1016_j_jep_2022_114988 crossref_primary_10_1016_j_chmed_2023_09_003 crossref_primary_10_1002_ibra_12007 |
Cites_doi | 10.7326/0003-4819-141-10-200411160-00009 10.1161/STROKEAHA.110.612358 10.1056/NEJMoa1408827 10.7326/0003-4819-152-11-201006010-00232 10.1161/STR.0b013e318284056a 10.1161/01.STR.30.8.1538 10.1001/jama.285.4.437 10.1136/bmj.i1754 10.1038/srep11743 10.1161/CIR.0000000000000366 10.1136/bmj.b2700 10.1161/01.STR.15.6.1039 10.1002/14651858.CD005568.pub2 10.1111/j.1538-7836.2011.04371.x 10.1016/S0140-6736(10)60491-6 |
ContentType | Journal Article |
Copyright | 2017 Elsevier Ltd Copyright © 2017 Elsevier Ltd. All rights reserved. 2017. Elsevier Ltd |
Copyright_xml | – notice: 2017 Elsevier Ltd – notice: Copyright © 2017 Elsevier Ltd. All rights reserved. – notice: 2017. Elsevier Ltd |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TS 7X7 7XB 88C 88E 88G 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9- K9. KB0 M0R M0S M0T M1P M2M M2O M7N MBDVC NAPCQ PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1016/j.ctim.2017.08.004 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central British Nursing Database ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Family Health Database (Proquest) Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Psychology Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China Physical Education Index ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Psychology MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-6963 |
EndPage | 85 |
ExternalDocumentID | 10_1016_j_ctim_2017_08_004 28917378 S0965229916303077 |
Genre | Meta-Analysis Journal Article Review |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 04C 0R~ 1B1 1P~ 1RT 1~. 1~5 3V. 4.4 457 4G. 53G 5GY 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAWTL AAXUO ABBQC ABJNI ABLVK ABMAC ABMZM ABUWG ABXDB ABYKQ ACDAQ ACGFS ACJTP ACPRK ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFKRA AFKWA AFRAH AFRHN AFTJW AFXBA AFXIZ AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AISVY AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AN0 ANZVX AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKNYI BKOJK BLXMC BMSDO BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EBD EBS EFJIC EFLBG EIHBH EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GROUPED_DOAJ GUQSH HEA HMCUK HMK HMO HVGLF HZ~ IAO IEA IHE IOF J1W J5H K9- KOM LCYCR LZ2 M0R M0T M1P M29 M2M M2O M2W M41 MO0 N9A NAHTW NAPCQ O-L O9- OAUVE OD~ OK1 OO0 OZT P-8 P-9 P2P PC. PQQKQ PROAC PSQYO PSYQQ Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SEL SES SEW SNG SNH SPCBC SSH SSZ T5K UHS UKHRP W2D WOW WUQ Z5R ~G- 0SF AAXKI ADVLN AFJKZ AKRWK ALIPV CGR CUY CVF ECM EIF ITC NPM AAYXX ACRPL CITATION 7TS 7XB 8FK K9. M7N MBDVC PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c384t-965badb5d2f3ab2b29f3cc62cf9b31c5fb7342acc8e234075ced6b1e5932667d3 |
IEDL.DBID | 7X7 |
ISSN | 0965-2299 |
IngestDate | Wed Dec 04 06:17:29 EST 2024 Thu Oct 10 22:49:48 EDT 2024 Fri Dec 06 05:46:31 EST 2024 Sat Sep 28 08:48:51 EDT 2024 Fri Feb 23 02:17:17 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | RR NIHSS NFDS Randomised controlled trials CI BI Dengzhan xixin Systematic review Meta-analysis CT Acute ischemic stroke DZXX MD Chinese herbal medicine vs |
Language | English |
License | Copyright © 2017 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c384t-965badb5d2f3ab2b29f3cc62cf9b31c5fb7342acc8e234075ced6b1e5932667d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Review-4 content type line 23 ObjectType-Undefined-3 |
PMID | 28917378 |
PQID | 2737307642 |
PQPubID | 1226357 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1940200237 proquest_journals_2737307642 crossref_primary_10_1016_j_ctim_2017_08_004 pubmed_primary_28917378 elsevier_sciencedirect_doi_10_1016_j_ctim_2017_08_004 |
PublicationCentury | 2000 |
PublicationDate | October 2017 2017-Oct 2017-10-00 20171001 |
PublicationDateYYYYMMDD | 2017-10-01 |
PublicationDate_xml | – month: 10 year: 2017 text: October 2017 |
PublicationDecade | 2010 |
PublicationPlace | Scotland |
PublicationPlace_xml | – name: Scotland – name: Kidlington |
PublicationTitle | Complementary therapies in medicine |
PublicationTitleAlternate | Complement Ther Med |
PublicationYear | 2017 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | 2016 (Accessed 20 February, 2016). Ozagrel (bib0245) 2009; 4 Shuai, Dong (bib0080) 1998; 8 World Health Organization. The top 10 causes of death. Li, Lei, Xie (bib0255) 2015; 40 Sandercock, Counsell, Kane (bib0050) 2015; 3 Wang, Chen, He, Ruan (bib0070) 1989 Lin, Wang, Liu (bib0075) 2003; 16 Ioannidis, Evans, Gotzsche (bib0275) 2004; 141 Lin (bib0225) 2012; 33 Lees, Bluhmki, von Kummer (bib0040) 2010; 15 Ioannidis, Lau (bib0250) 2001; 285 Tian, Zhou (bib0140) 2010; 19 Geng (bib0135) 2010; 12 Liberati, Altman, Tetzlaff (bib0100) 2009; 339 Yang, Zhang, Zhang (bib0260) 2005; 28 J. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Chen (bib0180) 2014; 22 Chen, Zhang (bib0165) 2014; 37 Huang, Ding, Fang (bib0240) 2005; 14 Liu, Zhang (bib0175) 2014; 29 Zhang (bib0170) 2011; 02 Jin, Luo (bib0235) 2013; 31 Dong (bib0155) 2007; 5 Wu, Liu, Zeng (bib0215) 2006; 27 Yang, Du, Wang, Li, Liu (bib0145) 2011; 32 Adeoye, Hornung, Khatri, Kleindorfer (bib0025) 2011; 42 Wang, Chen, Wang (bib0020) 2015; 5 (bib0115) 1996; 29 Mozaffarian, Benjamin, Go (bib0010) 2016; 133 Chen, He (bib0085) 1998; 7 Wang, Wang, Pan, Yang (bib0065) 2008; 33 Qian (bib0125) 2003; 10 Chen, Xiao (bib0220) 2015; 35 Saver, Starkman, Eckstein (bib0035) 2015; 372 Zhen, Kong, Li, Xu, Luo, Geng (bib0130) 2011; 34 Wang, Chen, Chen (bib0185) 2004; 11 Chen, He, Chen (bib0090) 1998; 7 Sulter, Steen, De Keyser (bib0110) 1999; 30 Rodrigues, Neves, Caldeira, Ferro, Ferreira, Costa (bib0045) 2016; 353 Li, Yan (bib0160) 2005; 5 Chen, Gao, Liu (bib0015) 2015; 30 Cao, Liu, Wu, Zhong, Liu (bib0095) 2008 Hou (bib0200) 2014 Jauch, Saver, Adams (bib0105) 2013; 44 Wu (bib0210) 2010; 31 2015, 246–257. Miao, Chen (bib0150) 2016; 31 Zhen, Li, Yang, Ou, Zhu (bib0190) 2010; 37 Neurological branch of Chinese Medical Association, cerebrovascular group of neurological branch of Chinese Medical Association. Chinese guideline for diagnosis and treatment of acute ischemic stroke 2014 Kotila, Waltimo, Niemi, Laaksonen, Lempinen (bib0265) 1984; 15 Zhou, Yang, Wang (bib0205) 2011; 38 Wu (bib0230) 2008 Chinese Pharmacopoeia Commission (bib0060) 2005 SAVER (bib0030) 2011; 9 Yu, Wei, Sun (bib0195) 2009; 28 Schulz, Altman, Moher (bib0270) 2010; 152 Zhen (10.1016/j.ctim.2017.08.004_bib0130) 2011; 34 Wang (10.1016/j.ctim.2017.08.004_bib0185) 2004; 11 Zhou (10.1016/j.ctim.2017.08.004_bib0205) 2011; 38 Yang (10.1016/j.ctim.2017.08.004_bib0145) 2011; 32 Ioannidis (10.1016/j.ctim.2017.08.004_bib0250) 2001; 285 Sandercock (10.1016/j.ctim.2017.08.004_bib0050) 2015; 3 (10.1016/j.ctim.2017.08.004_bib0115) 1996; 29 Lin (10.1016/j.ctim.2017.08.004_bib0225) 2012; 33 Tian (10.1016/j.ctim.2017.08.004_bib0140) 2010; 19 Li (10.1016/j.ctim.2017.08.004_bib0160) 2005; 5 Chinese Pharmacopoeia Commission (10.1016/j.ctim.2017.08.004_bib0060) 2005 Qian (10.1016/j.ctim.2017.08.004_bib0125) 2003; 10 Kotila (10.1016/j.ctim.2017.08.004_bib0265) 1984; 15 Li (10.1016/j.ctim.2017.08.004_bib0255) 2015; 40 Chen (10.1016/j.ctim.2017.08.004_bib0220) 2015; 35 SAVER (10.1016/j.ctim.2017.08.004_bib0030) 2011; 9 Liu (10.1016/j.ctim.2017.08.004_bib0175) 2014; 29 Ozagrel (10.1016/j.ctim.2017.08.004_bib0245) 2009; 4 Ioannidis (10.1016/j.ctim.2017.08.004_bib0275) 2004; 141 Chen (10.1016/j.ctim.2017.08.004_bib0165) 2014; 37 Chen (10.1016/j.ctim.2017.08.004_bib0085) 1998; 7 Jauch (10.1016/j.ctim.2017.08.004_bib0105) 2013; 44 Mozaffarian (10.1016/j.ctim.2017.08.004_bib0010) 2016; 133 Chen (10.1016/j.ctim.2017.08.004_bib0090) 1998; 7 Wu (10.1016/j.ctim.2017.08.004_bib0210) 2010; 31 Wang (10.1016/j.ctim.2017.08.004_bib0070) 1989 Geng (10.1016/j.ctim.2017.08.004_bib0135) 2010; 12 Zhang (10.1016/j.ctim.2017.08.004_bib0170) 2011; 02 10.1016/j.ctim.2017.08.004_bib0005 Chen (10.1016/j.ctim.2017.08.004_bib0015) 2015; 30 Dong (10.1016/j.ctim.2017.08.004_bib0155) 2007; 5 Wang (10.1016/j.ctim.2017.08.004_bib0020) 2015; 5 Adeoye (10.1016/j.ctim.2017.08.004_bib0025) 2011; 42 10.1016/j.ctim.2017.08.004_bib0055 Wang (10.1016/j.ctim.2017.08.004_bib0065) 2008; 33 Liberati (10.1016/j.ctim.2017.08.004_bib0100) 2009; 339 Yu (10.1016/j.ctim.2017.08.004_bib0195) 2009; 28 Lin (10.1016/j.ctim.2017.08.004_bib0075) 2003; 16 Wu (10.1016/j.ctim.2017.08.004_bib0215) 2006; 27 Jin (10.1016/j.ctim.2017.08.004_bib0235) 2013; 31 Zhen (10.1016/j.ctim.2017.08.004_bib0190) 2010; 37 Hou (10.1016/j.ctim.2017.08.004_bib0200) 2014 Huang (10.1016/j.ctim.2017.08.004_bib0240) 2005; 14 Shuai (10.1016/j.ctim.2017.08.004_bib0080) 1998; 8 Yang (10.1016/j.ctim.2017.08.004_bib0260) 2005; 28 Rodrigues (10.1016/j.ctim.2017.08.004_bib0045) 2016; 353 Sulter (10.1016/j.ctim.2017.08.004_bib0110) 1999; 30 Chen (10.1016/j.ctim.2017.08.004_bib0180) 2014; 22 Lees (10.1016/j.ctim.2017.08.004_bib0040) 2010; 15 Wu (10.1016/j.ctim.2017.08.004_bib0230) 2008 Schulz (10.1016/j.ctim.2017.08.004_bib0270) 2010; 152 10.1016/j.ctim.2017.08.004_bib0120 Cao (10.1016/j.ctim.2017.08.004_bib0095) 2008 Saver (10.1016/j.ctim.2017.08.004_bib0035) 2015; 372 Miao (10.1016/j.ctim.2017.08.004_bib0150) 2016; 31 |
References_xml | – volume: 3 start-page: CD000024 year: 2015 ident: bib0050 article-title: Anticoagulants for acute ischaemic stroke publication-title: Cochrane Database Syst Rev contributor: fullname: Kane – volume: 32 start-page: 2854 year: 2011 end-page: 2856 ident: bib0145 article-title: Clinical investigation of Dengzhan Xixin combined with edaravone in the treatment of 145 patients with acute cerebral infarction publication-title: Guangdong Med J contributor: fullname: Liu – volume: 12 start-page: 105 year: 2010 ident: bib0135 article-title: Investigation of Dengzhan Xixin injection for acute cerebral infarction publication-title: Mod Med J Chin contributor: fullname: Geng – volume: 42 start-page: 1952 year: 2011 end-page: 1955 ident: bib0025 article-title: Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states: a doubling of treatment rates over the course of 5 years publication-title: Stroke contributor: fullname: Kleindorfer – volume: 5 start-page: 11743 year: 2015 ident: bib0020 article-title: Comparison of therapeutic effect of recombinant tissue plasminogen activator by treatment time after onset of acute ischemic stroke publication-title: Sci Rep-Uk contributor: fullname: Wang – volume: 11 start-page: 921 year: 2004 end-page: 922 ident: bib0185 article-title: Curative effect of Dengzhan Xixin injection for cerebral infarction publication-title: Chin J Med Writ contributor: fullname: Chen – volume: 7 start-page: 42 year: 1998 end-page: 46 ident: bib0090 article-title: Mechanisms of inhibitory effects of breviscapine on lipid peroxidation in rat brain mitochondria publication-title: J Chin Pharm Sci. contributor: fullname: Chen – volume: 28 start-page: 608 year: 2009 end-page: 609 ident: bib0195 article-title: Dengzhan Xixin injection in the treatment of 298 patients with acute ischemic stroke publication-title: Herald Med contributor: fullname: Sun – volume: 15 start-page: 1695 year: 2010 end-page: 1703 ident: bib0040 article-title: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials publication-title: Lancet contributor: fullname: von Kummer – volume: 28 start-page: 40 year: 2005 end-page: 41 ident: bib0260 article-title: Comparison of Dengzhan Xixin injection and Dengzhanhua on clinical application and chemical constituents publication-title: J Chengdu Univ TCM contributor: fullname: Zhang – volume: 37 start-page: 46 year: 2010 end-page: 47 ident: bib0190 article-title: Dengzhan Xixin for treatment of 35 cases of acute cerebral infarction publication-title: Chin J Pract Med contributor: fullname: Zhu – volume: 30 start-page: 1538 year: 1999 end-page: 1541 ident: bib0110 article-title: Use of the barthel index and modified rankin scale in acute stroke trials publication-title: Stroke contributor: fullname: De Keyser – volume: 372 start-page: 528 year: 2015 end-page: 536 ident: bib0035 article-title: Prehospital use of magnesium sulfate as neuroprotection in acute stroke publication-title: N Engl J Med contributor: fullname: Eckstein – volume: 44 start-page: 870 year: 2013 end-page: 947 ident: bib0105 article-title: Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association publication-title: Stroke contributor: fullname: Adams – volume: 38 start-page: 2660 year: 2011 end-page: 2661 ident: bib0205 article-title: Effect of Erigeron injection on MMP-9 in patient with acute cerebral infarction publication-title: Mod Pre Med contributor: fullname: Wang – volume: 35 start-page: 6383 year: 2015 end-page: 6385 ident: bib0220 article-title: Effects of Dengzhan Xixin injection on excutive function of acute ischemic stroke patients publication-title: Chin J Gerontol contributor: fullname: Xiao – volume: 339 start-page: b2700 year: 2009 ident: bib0100 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration publication-title: BMJ contributor: fullname: Tetzlaff – volume: 22 start-page: 17 year: 2014 end-page: 18 ident: bib0180 article-title: Comparision of curative effect of alprostadil injection combined with fleabane injection on cerebral infarction publication-title: Chin J Trauma Disabil Med contributor: fullname: Chen – volume: 285 start-page: 437 year: 2001 end-page: 443 ident: bib0250 article-title: Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas publication-title: JAMA contributor: fullname: Lau – volume: 141 start-page: 781 year: 2004 end-page: 788 ident: bib0275 article-title: Better reporting of harms in randomized trials: an extension of the CONSORT statement publication-title: Ann Intern Med contributor: fullname: Gotzsche – volume: 5 start-page: 3316 year: 2005 end-page: 3317 ident: bib0160 article-title: Clinical observation of Dengzhan Xixin and low-molecular-weight heparin in the treatment of acute cerebral infarction publication-title: Chin J Misdiagn contributor: fullname: Yan – volume: 40 start-page: 4757 year: 2015 end-page: 4761 ident: bib0255 article-title: A postmarketing surveillance study on 31 724 patients using Dengzhan Xixin injection in hospital publication-title: Chin J Chin Mater Med contributor: fullname: Xie – volume: 10 start-page: 298 year: 2003 ident: bib0125 article-title: Clinical observation of Dengzhan Xixin injection combined with cerebrolysin for 38 cases of acute cerebral infarction publication-title: Chin J Integr Tradit Chin West Med Intensive Crit Care contributor: fullname: Qian – volume: 37 start-page: 1096 year: 2014 end-page: 1098 ident: bib0165 article-title: Clinical observation of Dengzhan Xixin injection combined with clopidogrel in the treatment of acute cerebral infarction publication-title: J Chin Med Mater contributor: fullname: Zhang – volume: 31 start-page: 1390 year: 2013 end-page: 1392 ident: bib0235 article-title: Erigeron injection in treatment of ischemic stroke and its influence on serum hs-CRP and UA levels publication-title: Chin Arch Tradit Chin Med contributor: fullname: Luo – volume: 31 start-page: 238 year: 2010 end-page: 239 ident: bib0210 article-title: Effects of Dengzhan Xixin injection on acute cerebral infarction and myocardial enzymes publication-title: Guangdong Med J contributor: fullname: Wu – year: 2014 ident: bib0200 article-title: Effect of Dengzhan Xixin on serum level of VEGF, MMP-9, EPCs in acute cerebral infarction patients with blood stasis syndrome. Master dissertation contributor: fullname: Hou – volume: 33 start-page: 1681 year: 2008 end-page: 1683 ident: bib0065 article-title: HPLC determination of four active components in Dengzhan Xixin injection publication-title: China J Chin Mater Med contributor: fullname: Yang – volume: 8 start-page: 3 year: 1998 end-page: 85 ident: bib0080 article-title: Protective effect of PKC inhibitor breviscapine on brain cells against ischemic-reperfusion damage publication-title: Chin Pharmacol Bull contributor: fullname: Dong – volume: 15 start-page: 1039 year: 1984 end-page: 1044 ident: bib0265 article-title: The profile of recovery from stroke and factors influencing outcome publication-title: Stroke contributor: fullname: Lempinen – volume: 133 start-page: 447 year: 2016 end-page: 454 ident: bib0010 article-title: Executive summary. heart disease and stroke statistics—2016 update publication-title: Circulation contributor: fullname: Go – volume: 152 start-page: 726 year: 2010 end-page: 732 ident: bib0270 article-title: CONSORT 2010 statement: updated guidelines forreporting parallel group randomized trials publication-title: Ann Intern Med contributor: fullname: Moher – volume: 31 start-page: 41 year: 2016 end-page: 44 ident: bib0150 article-title: Clinical investigation of Dengzhan Xixin injection combined with citicoline capsules in the treatment of cerebral infarction publication-title: Drugs Clin contributor: fullname: Chen – year: 2008 ident: bib0095 article-title: Dengzhanhua preparations for acute cerebral infarction publication-title: Cochrane Database Syst Rev contributor: fullname: Liu – volume: 4 start-page: 147 year: 2009 end-page: 148 ident: bib0245 article-title: Dengzhan Xixin in the treatment of 35 cases of cerebral infarction publication-title: China Pract Med contributor: fullname: Ozagrel – volume: 353 start-page: i1754 year: 2016 ident: bib0045 article-title: Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis publication-title: BMJ contributor: fullname: Costa – volume: 16 start-page: 375 year: 2003 ident: bib0075 article-title: Effects of Dengzhan Xixin injection on hemarheology of cerebral infarction patients publication-title: J Clin Neurol contributor: fullname: Liu – volume: 34 start-page: 1642 year: 2011 end-page: 1644 ident: bib0130 article-title: Effect of Dengzhan Xixin injection on expression of serum protein S100 and neurological function in acute cerebral infarction patients publication-title: Chin Med Mater contributor: fullname: Geng – volume: 7 start-page: 35 year: 1998 end-page: 37 ident: bib0085 article-title: Effects of breviscapine on the changes in antioxidant enzyme activity induced by cerebral ischemia-reperfusion in rats publication-title: J Chin Pharm Sci contributor: fullname: He – volume: 02 start-page: 15 year: 2011 end-page: 16 ident: bib0170 article-title: Clinical observation of ozagrel in treatment of acute cerebral infarction publication-title: Chin Manipul Rehabil Med contributor: fullname: Zhang – volume: 14 start-page: 1964 year: 2005 end-page: 1965 ident: bib0240 article-title: Investigation on the curative effect of Dengzhan Xixin injection for acute cerebral infarction publication-title: Mod J Integr Tradit West Med contributor: fullname: Fang – volume: 5 start-page: 119 year: 2007 end-page: 121 ident: bib0155 article-title: Clinical investigation on curative effect of fibrinogenase injection for acute cerebral infarction publication-title: Chin J Intergr Med Cardio-cerebrovascular Dis contributor: fullname: Dong – year: 2008 ident: bib0230 article-title: Effects of Dengzhan Xixin on VEGF, sICAM of Acute Cerebral Infarction with Blood Stasis Pattern. Master Dissertation contributor: fullname: Wu – volume: 27 start-page: 1088 year: 2006 end-page: 1089 ident: bib0215 article-title: Effects of Dengzhan Xixin injection on acute ischemic infarction and hemorheology publication-title: Guangdong Med J contributor: fullname: Zeng – volume: 30 start-page: 617 year: 2015 end-page: 622 ident: bib0015 article-title: Summary of reports of chinese cardiovascular diseases 2014 publication-title: Chin Circul J contributor: fullname: Liu – volume: 9 start-page: 333 year: 2011 end-page: 343 ident: bib0030 article-title: Improving reperfusion therapy for acute ischaemic stroke publication-title: J Thromb Haemost. contributor: fullname: SAVER – volume: 29 start-page: 1210 year: 2014 end-page: 1212 ident: bib0175 article-title: Clinical research on Dengzhan Xixin injection and urinarykallikrein in treatment of acute ischemic stroke publication-title: China J Chin Med contributor: fullname: Zhang – start-page: 447 year: 2005 end-page: 448 ident: bib0060 article-title: Chinese Pharmacopoeia contributor: fullname: Chinese Pharmacopoeia Commission – year: 1989 ident: bib0070 article-title: Inhibitory effects of new breviscapine on thrombosis in vivo publication-title: Zhong Xi Yi Jie He Za Zhi contributor: fullname: Ruan – volume: 29 start-page: 381 year: 1996 end-page: 383 ident: bib0115 article-title: The Fourth National Cerebrovascular Conference. Cerebral apoplexy patients clinical nerve function deficit score criteria publication-title: Chin J Neurol – volume: 19 start-page: 1102 year: 2010 end-page: 1103 ident: bib0140 article-title: Clinical investigation of combination therapy of Traditional Chinese Medicine & Western Medicine for 36 patients with acute cerebral infarction publication-title: J Emerg Tradit Chin Med contributor: fullname: Zhou – volume: 33 start-page: 2339 year: 2012 end-page: 2340 ident: bib0225 article-title: Effects of Dengzhan Xixin injection on PaO publication-title: Guangdong Med J contributor: fullname: Lin – volume: 141 start-page: 781 year: 2004 ident: 10.1016/j.ctim.2017.08.004_bib0275 article-title: Better reporting of harms in randomized trials: an extension of the CONSORT statement publication-title: Ann Intern Med doi: 10.7326/0003-4819-141-10-200411160-00009 contributor: fullname: Ioannidis – volume: 37 start-page: 46 year: 2010 ident: 10.1016/j.ctim.2017.08.004_bib0190 article-title: Dengzhan Xixin for treatment of 35 cases of acute cerebral infarction publication-title: Chin J Pract Med contributor: fullname: Zhen – volume: 42 start-page: 1952 year: 2011 ident: 10.1016/j.ctim.2017.08.004_bib0025 article-title: Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states: a doubling of treatment rates over the course of 5 years publication-title: Stroke doi: 10.1161/STROKEAHA.110.612358 contributor: fullname: Adeoye – volume: 372 start-page: 528 year: 2015 ident: 10.1016/j.ctim.2017.08.004_bib0035 article-title: Prehospital use of magnesium sulfate as neuroprotection in acute stroke publication-title: N Engl J Med doi: 10.1056/NEJMoa1408827 contributor: fullname: Saver – start-page: 447 year: 2005 ident: 10.1016/j.ctim.2017.08.004_bib0060 contributor: fullname: Chinese Pharmacopoeia Commission – volume: 02 start-page: 15 year: 2011 ident: 10.1016/j.ctim.2017.08.004_bib0170 article-title: Clinical observation of ozagrel in treatment of acute cerebral infarction publication-title: Chin Manipul Rehabil Med contributor: fullname: Zhang – volume: 152 start-page: 726 year: 2010 ident: 10.1016/j.ctim.2017.08.004_bib0270 article-title: CONSORT 2010 statement: updated guidelines forreporting parallel group randomized trials publication-title: Ann Intern Med doi: 10.7326/0003-4819-152-11-201006010-00232 contributor: fullname: Schulz – volume: 44 start-page: 870 year: 2013 ident: 10.1016/j.ctim.2017.08.004_bib0105 article-title: Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association publication-title: Stroke doi: 10.1161/STR.0b013e318284056a contributor: fullname: Jauch – volume: 30 start-page: 617 year: 2015 ident: 10.1016/j.ctim.2017.08.004_bib0015 article-title: Summary of reports of chinese cardiovascular diseases 2014 publication-title: Chin Circul J contributor: fullname: Chen – volume: 22 start-page: 17 year: 2014 ident: 10.1016/j.ctim.2017.08.004_bib0180 article-title: Comparision of curative effect of alprostadil injection combined with fleabane injection on cerebral infarction publication-title: Chin J Trauma Disabil Med contributor: fullname: Chen – volume: 4 start-page: 147 year: 2009 ident: 10.1016/j.ctim.2017.08.004_bib0245 article-title: Dengzhan Xixin in the treatment of 35 cases of cerebral infarction publication-title: China Pract Med contributor: fullname: Ozagrel – volume: 31 start-page: 238 year: 2010 ident: 10.1016/j.ctim.2017.08.004_bib0210 article-title: Effects of Dengzhan Xixin injection on acute cerebral infarction and myocardial enzymes publication-title: Guangdong Med J contributor: fullname: Wu – ident: 10.1016/j.ctim.2017.08.004_bib0120 – year: 2008 ident: 10.1016/j.ctim.2017.08.004_bib0230 contributor: fullname: Wu – volume: 30 start-page: 1538 year: 1999 ident: 10.1016/j.ctim.2017.08.004_bib0110 article-title: Use of the barthel index and modified rankin scale in acute stroke trials publication-title: Stroke doi: 10.1161/01.STR.30.8.1538 contributor: fullname: Sulter – volume: 35 start-page: 6383 year: 2015 ident: 10.1016/j.ctim.2017.08.004_bib0220 article-title: Effects of Dengzhan Xixin injection on excutive function of acute ischemic stroke patients publication-title: Chin J Gerontol contributor: fullname: Chen – volume: 33 start-page: 1681 year: 2008 ident: 10.1016/j.ctim.2017.08.004_bib0065 article-title: HPLC determination of four active components in Dengzhan Xixin injection publication-title: China J Chin Mater Med contributor: fullname: Wang – volume: 3 start-page: CD000024 year: 2015 ident: 10.1016/j.ctim.2017.08.004_bib0050 article-title: Anticoagulants for acute ischaemic stroke publication-title: Cochrane Database Syst Rev contributor: fullname: Sandercock – volume: 28 start-page: 608 year: 2009 ident: 10.1016/j.ctim.2017.08.004_bib0195 article-title: Dengzhan Xixin injection in the treatment of 298 patients with acute ischemic stroke publication-title: Herald Med contributor: fullname: Yu – volume: 31 start-page: 1390 year: 2013 ident: 10.1016/j.ctim.2017.08.004_bib0235 article-title: Erigeron injection in treatment of ischemic stroke and its influence on serum hs-CRP and UA levels publication-title: Chin Arch Tradit Chin Med contributor: fullname: Jin – volume: 7 start-page: 42 year: 1998 ident: 10.1016/j.ctim.2017.08.004_bib0090 article-title: Mechanisms of inhibitory effects of breviscapine on lipid peroxidation in rat brain mitochondria publication-title: J Chin Pharm Sci. contributor: fullname: Chen – volume: 285 start-page: 437 year: 2001 ident: 10.1016/j.ctim.2017.08.004_bib0250 article-title: Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas publication-title: JAMA doi: 10.1001/jama.285.4.437 contributor: fullname: Ioannidis – volume: 353 start-page: i1754 year: 2016 ident: 10.1016/j.ctim.2017.08.004_bib0045 article-title: Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis publication-title: BMJ doi: 10.1136/bmj.i1754 contributor: fullname: Rodrigues – volume: 5 start-page: 119 year: 2007 ident: 10.1016/j.ctim.2017.08.004_bib0155 article-title: Clinical investigation on curative effect of fibrinogenase injection for acute cerebral infarction publication-title: Chin J Intergr Med Cardio-cerebrovascular Dis contributor: fullname: Dong – volume: 5 start-page: 3316 year: 2005 ident: 10.1016/j.ctim.2017.08.004_bib0160 article-title: Clinical observation of Dengzhan Xixin and low-molecular-weight heparin in the treatment of acute cerebral infarction publication-title: Chin J Misdiagn contributor: fullname: Li – volume: 29 start-page: 381 year: 1996 ident: 10.1016/j.ctim.2017.08.004_bib0115 article-title: The Fourth National Cerebrovascular Conference. Cerebral apoplexy patients clinical nerve function deficit score criteria publication-title: Chin J Neurol – volume: 14 start-page: 1964 year: 2005 ident: 10.1016/j.ctim.2017.08.004_bib0240 article-title: Investigation on the curative effect of Dengzhan Xixin injection for acute cerebral infarction publication-title: Mod J Integr Tradit West Med contributor: fullname: Huang – volume: 5 start-page: 11743 year: 2015 ident: 10.1016/j.ctim.2017.08.004_bib0020 article-title: Comparison of therapeutic effect of recombinant tissue plasminogen activator by treatment time after onset of acute ischemic stroke publication-title: Sci Rep-Uk doi: 10.1038/srep11743 contributor: fullname: Wang – volume: 133 start-page: 447 year: 2016 ident: 10.1016/j.ctim.2017.08.004_bib0010 article-title: Executive summary. heart disease and stroke statistics—2016 update publication-title: Circulation doi: 10.1161/CIR.0000000000000366 contributor: fullname: Mozaffarian – volume: 32 start-page: 2854 year: 2011 ident: 10.1016/j.ctim.2017.08.004_bib0145 article-title: Clinical investigation of Dengzhan Xixin combined with edaravone in the treatment of 145 patients with acute cerebral infarction publication-title: Guangdong Med J contributor: fullname: Yang – volume: 31 start-page: 41 year: 2016 ident: 10.1016/j.ctim.2017.08.004_bib0150 article-title: Clinical investigation of Dengzhan Xixin injection combined with citicoline capsules in the treatment of cerebral infarction publication-title: Drugs Clin contributor: fullname: Miao – volume: 339 start-page: b2700 year: 2009 ident: 10.1016/j.ctim.2017.08.004_bib0100 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration publication-title: BMJ doi: 10.1136/bmj.b2700 contributor: fullname: Liberati – volume: 15 start-page: 1039 year: 1984 ident: 10.1016/j.ctim.2017.08.004_bib0265 article-title: The profile of recovery from stroke and factors influencing outcome publication-title: Stroke doi: 10.1161/01.STR.15.6.1039 contributor: fullname: Kotila – year: 2014 ident: 10.1016/j.ctim.2017.08.004_bib0200 contributor: fullname: Hou – volume: 7 start-page: 35 year: 1998 ident: 10.1016/j.ctim.2017.08.004_bib0085 article-title: Effects of breviscapine on the changes in antioxidant enzyme activity induced by cerebral ischemia-reperfusion in rats publication-title: J Chin Pharm Sci contributor: fullname: Chen – volume: 28 start-page: 40 year: 2005 ident: 10.1016/j.ctim.2017.08.004_bib0260 article-title: Comparison of Dengzhan Xixin injection and Dengzhanhua on clinical application and chemical constituents publication-title: J Chengdu Univ TCM contributor: fullname: Yang – volume: 34 start-page: 1642 year: 2011 ident: 10.1016/j.ctim.2017.08.004_bib0130 article-title: Effect of Dengzhan Xixin injection on expression of serum protein S100 and neurological function in acute cerebral infarction patients publication-title: Chin Med Mater contributor: fullname: Zhen – volume: 40 start-page: 4757 year: 2015 ident: 10.1016/j.ctim.2017.08.004_bib0255 article-title: A postmarketing surveillance study on 31 724 patients using Dengzhan Xixin injection in hospital publication-title: Chin J Chin Mater Med contributor: fullname: Li – volume: 16 start-page: 375 year: 2003 ident: 10.1016/j.ctim.2017.08.004_bib0075 article-title: Effects of Dengzhan Xixin injection on hemarheology of cerebral infarction patients publication-title: J Clin Neurol contributor: fullname: Lin – volume: 29 start-page: 1210 year: 2014 ident: 10.1016/j.ctim.2017.08.004_bib0175 article-title: Clinical research on Dengzhan Xixin injection and urinarykallikrein in treatment of acute ischemic stroke publication-title: China J Chin Med contributor: fullname: Liu – volume: 11 start-page: 921 year: 2004 ident: 10.1016/j.ctim.2017.08.004_bib0185 article-title: Curative effect of Dengzhan Xixin injection for cerebral infarction publication-title: Chin J Med Writ contributor: fullname: Wang – volume: 38 start-page: 2660 year: 2011 ident: 10.1016/j.ctim.2017.08.004_bib0205 article-title: Effect of Erigeron injection on MMP-9 in patient with acute cerebral infarction publication-title: Mod Pre Med contributor: fullname: Zhou – ident: 10.1016/j.ctim.2017.08.004_bib0055 – year: 2008 ident: 10.1016/j.ctim.2017.08.004_bib0095 article-title: Dengzhanhua preparations for acute cerebral infarction publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD005568.pub2 contributor: fullname: Cao – volume: 9 start-page: 333 year: 2011 ident: 10.1016/j.ctim.2017.08.004_bib0030 article-title: Improving reperfusion therapy for acute ischaemic stroke publication-title: J Thromb Haemost. doi: 10.1111/j.1538-7836.2011.04371.x contributor: fullname: SAVER – volume: 10 start-page: 298 year: 2003 ident: 10.1016/j.ctim.2017.08.004_bib0125 article-title: Clinical observation of Dengzhan Xixin injection combined with cerebrolysin for 38 cases of acute cerebral infarction publication-title: Chin J Integr Tradit Chin West Med Intensive Crit Care contributor: fullname: Qian – volume: 27 start-page: 1088 year: 2006 ident: 10.1016/j.ctim.2017.08.004_bib0215 article-title: Effects of Dengzhan Xixin injection on acute ischemic infarction and hemorheology publication-title: Guangdong Med J contributor: fullname: Wu – volume: 12 start-page: 105 year: 2010 ident: 10.1016/j.ctim.2017.08.004_bib0135 article-title: Investigation of Dengzhan Xixin injection for acute cerebral infarction publication-title: Mod Med J Chin contributor: fullname: Geng – volume: 33 start-page: 2339 year: 2012 ident: 10.1016/j.ctim.2017.08.004_bib0225 article-title: Effects of Dengzhan Xixin injection on PaO2 and PaCO2 of acute cerebral infarction patients publication-title: Guangdong Med J contributor: fullname: Lin – volume: 8 start-page: 3 year: 1998 ident: 10.1016/j.ctim.2017.08.004_bib0080 article-title: Protective effect of PKC inhibitor breviscapine on brain cells against ischemic-reperfusion damage publication-title: Chin Pharmacol Bull contributor: fullname: Shuai – ident: 10.1016/j.ctim.2017.08.004_bib0005 – volume: 15 start-page: 1695 issue: 375 year: 2010 ident: 10.1016/j.ctim.2017.08.004_bib0040 article-title: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials publication-title: Lancet doi: 10.1016/S0140-6736(10)60491-6 contributor: fullname: Lees – volume: 37 start-page: 1096 year: 2014 ident: 10.1016/j.ctim.2017.08.004_bib0165 article-title: Clinical observation of Dengzhan Xixin injection combined with clopidogrel in the treatment of acute cerebral infarction publication-title: J Chin Med Mater contributor: fullname: Chen – year: 1989 ident: 10.1016/j.ctim.2017.08.004_bib0070 article-title: Inhibitory effects of new breviscapine on thrombosis in vivo publication-title: Zhong Xi Yi Jie He Za Zhi contributor: fullname: Wang – volume: 19 start-page: 1102 year: 2010 ident: 10.1016/j.ctim.2017.08.004_bib0140 article-title: Clinical investigation of combination therapy of Traditional Chinese Medicine & Western Medicine for 36 patients with acute cerebral infarction publication-title: J Emerg Tradit Chin Med contributor: fullname: Tian |
SSID | ssj0009373 |
Score | 2.340666 |
SecondaryResourceType | review_article |
Snippet | •The effectiveness and safety of DZXX injection for AIS was analysed.•It appears that DZXX can additionally improve neurological function for AIS patients.•The... To evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic stroke. Systematic... ObjectiveTo evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic... OBJECTIVETo evaluate the effectiveness and safety of Chinese herbal medicine Dengzhan Xixin (Erigeron breviscapus) injection for acute ischemic... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 74 |
SubjectTerms | Acute ischemic stroke Adverse events Aged Aged, 80 and over Anticoagulants Bias Brain Brain Ischemia - complications Brain Ischemia - drug therapy Chinese herbal medicine Clinical trials Dengzhan xixin Drug dosages Drugs, Chinese Herbal - therapeutic use Erigeron FDA approval Female Herbal medicine Humans Injection Injections Ischemia Kinases Male Meta-analysis Middle Aged Palliative care Performance evaluation Phytotherapy Quality assessment Quality of life Randomised controlled trials Software Stroke Stroke - drug therapy Stroke - etiology Systematic review |
SummonAdditionalLinks | – databaseName: ScienceDirect Freedom Collection dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB5qC-KLtF5PbWUF3yQcs5tkE98OvXBU2hctnLdlb9G0silNDkj_Rf9xZ5JNi2B98CXktmGZmcx8w9wA3huXyRpheILmXNAIM5GUpeGJtmjO8zp1dojonpwWy7PsyypfbcDBVAtDaZVR9486fdDW8c48UnN-2TTzb9S3hHPCN4IkVT6CLTRHFKvdWnz-ujy9770rxkBzRQlduCDWzoxpXqhVqCA9lUMnzziv7S_26SH8Odih4214GgEkW4x73IENH57B45MYIn8ONzQR23eeITMMvjgFz9mhDz-uf-rAVs3vJrAmnA9ZWIEhbGXarnvPGnR1KVmedf1Ve-E_sQW77_TMxioXpoPDj_Y60bGfCWtrhhbPtSgy3rGY_P4LT4eRIN0LODs--n6wTOLchcSKMusTpJPRzuSO10IbbnhVC2sLbuvKiNTmtZEi49ra0nOBDmGOvCpM6nPCgoV04iVshjb418BKn0rvZemynHwro4uaFx6PVaY5LpvBh4na6nJsr6GmvLNzRbxRxBtFozI_ZjPIJ4aoP4REof7_57q9iXsq_qKdQtyG2k2i_zWDd3ePkVIUMdHBt-tOpRW51whr5AxejVy_2yZ6qil-otz9z029gSd0NSYG7sFmf7X2-whwevM2CvAtMC37JQ priority: 102 providerName: Elsevier |
Title | Chinese herbal medicine Dengzhan Xixin injection for acute ischemic stroke: A systematic review and meta-analysis of randomised controlled trials |
URI | https://dx.doi.org/10.1016/j.ctim.2017.08.004 https://www.ncbi.nlm.nih.gov/pubmed/28917378 https://www.proquest.com/docview/2737307642 https://search.proquest.com/docview/1940200237 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7ygNJLadLXpsmiQm_FbSXZlt1L2LzYtmQppYG9Cb3cblrkJPZC6aH_If84I1vOXpJcbINtYTTjmW80n2YA3mqbigpheILunIcWZjwpCs0SZdCdZxW1psvons7y6Vn6ZZ7N44JbE2mVg03sDLWtTVgj_4BuFpVRIFzev7hMQteokF2NLTTWYZMydOWoz2IuVkV3eZ9hLgOTC-1u3DTT87vQnISd6FR0JTxjo7Y7HNN9wLNzQCdP4UlEjmTSi3oL1pzfhkenMTf-DK5DK2zXOIJS0PjgkDUnR87__PdLeTJf_F14svDnHf3KE8SrRJll68gCY9zAkidNe1X_dp_IhKxKPJN-ewtR3uKgrUpULGRC6oqgq7M16oqzJLLe_-Bl1wukeQ5nJ8c_DqdJbLiQGF6kbYLzpJXVmWUVV5ppVlbcmJyZqtScmqzSgqdMGVM4xjESzIyzuaYuCyAwF5a_gA1fe_cKSOGocE4UNs1CUKVVXrHc4bFMFcPXRvBumG150dfVkAPh7FwG2cggGxl6ZH5MR5ANApERGfQeX6Lhf_C93UF6Mv6bjVxp0gje3N7GmQqpEuVdvWwkLUNcjXhGjOBlL_Xbz8QQleIQxc7Dg7-Gx-FLeuLfLmy0V0u3hwCm1WNYf_-fjjtdHcPm5PPX6QzPB8ezb99vAO6q9Qs |
link.rule.ids | 314,780,784,4502,12056,21388,24116,27924,27925,31719,31720,33744,33745,43310,43805,45585,45679,73745,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVgIuiGdZWsBI3FAEseM8uKAWWi3QXSHUSnuz_JjAFuSUJitV_Av-cceJ071AL1GkxFbkmcx84xnPB_DKuKyoCYYn5M5FoDATSVkanmhL7lzWqbN9Rne-yGcn2eelXMYNtzaWVY42sTfUrrFhj_wNuVlSxoLg8vuz30lgjQrZ1UihcRO2Qud0OYGt_YPF12-btrtiyDFXoZaLLG88NjNUeJFBCWfR06Jv4hmp2v7hmv4HPXsXdHgP7kbsyPYGYd-HG-gfwK15zI4_hL-BDBtbZCQHQy-OeXP2Ef33Pz-0Z8vVxcqzlT_tC7A8I8TKtF13yFYU5YY6edZ2581PfMf22KbJMxsOuDDtHU3a6UTHViasqRk5O9eQtqBjse79F932bCDtIzg5PDj-MEsi5UJiRZl1Ca2T0c5Ix2uhDTe8qoW1Obd1ZURqZW0KkXFtbYlcUCwoLbrcpCgDDMwLJx7DxDcenwArMS0Qi9JlMoRVRuc1z5GuVaY5DZvC63G11dnQWUONJWenKshGBdmowJL5NpuCHAWiIjYYfL4i03_tuN1Reir-na3a6NIUXl49ppUKyRLtsVm3Kq1CZE2IppjC9iD1q8-kIDWlKcqn10_-Am7PjudH6ujT4ssO3AlfNZQB7sKkO1_jM4IznXkedfYSpHb1Ow |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB70FIov4t2jVUfwTUKb3Vz7Iq3toV56KGLhvC17rafKpjY5IP0X_uPOJpueF-1LCCRZws5kv28y384AvFMmKx3R8ITgnIcWZjypKsUSqQnOc5ca3Wd0j-fF0Wn2eZEvov6pjbLKcU3sF2rT6PCPfJtglpyxJLq87aIs4uRg9uHidxI6SIVMa2yncRc2CBV32AQ29g_nJ9_WJXj5kG-ug66LVuG4hWZQe9HiEvalp2Vf0DO2bfsHTP2PhvZwNHsA9yOPxL3B8A_hjvWPYPM4Zsofw9_QGNu2Fskmim4cc-h4YP3Z1Q_pcbH8s_S49Oe9GMsjsVeUetVZXFLEGzTz2HaXzU-7i3u4LviMw2YXlN7QoJ1MZCxrgo1DAj7TkOdYg1ED_4tO-84g7RM4nR1-_3iUxPYLieZV1iU0T0oalRvmuFRMsdpxrQumXa14qnOnSp4xqXVlGae4MNfWFCq1eaCERWn4U5j4xtvngJVNS2vLymR5CLGULBwrLB3rTDJ6bArvx9kWF0OVDTHKz85FsI0IthGhY-ZONoV8NIiIPGHAf0EwcOtzW6P1RPxSW7H2qym8vblMMxUSJ9LbZtWKtA5RNrGbcgrPBqvfvCYFrCkNUb24ffA3sEnuKr5-mn95CffCSw2KwC2YdJcr-4qYTadeR5e9BunD-Wg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chinese+herbal+medicine+Dengzhan+Xixin+injection+for+acute+ischemic+stroke%3A+A+systematic+review+and+meta-analysis+of+randomised+controlled+trials&rft.jtitle=Complementary+therapies+in+medicine&rft.au=Li%2C+Jin-Gen&rft.au=Wang%2C+Li-Qiong&rft.au=Yang%2C+Xiao-Ying&rft.au=Chen%2C+Zhuo&rft.date=2017-10-01&rft.eissn=1873-6963&rft.volume=34&rft.spage=74&rft_id=info:doi/10.1016%2Fj.ctim.2017.08.004&rft_id=info%3Apmid%2F28917378&rft.externalDocID=28917378 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0965-2299&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0965-2299&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0965-2299&client=summon |